Evidence map›Paper›PMID 36344615›Full record

ArticleScientific reports2022

Prevalence and associations of dry eye disease and meibomian gland dysfunction in the ural eye and medical study.

Mukharram M Bikbov, Timur R Gilmanshin, Rinat M Zainullin, Gyulli M Kazakbaeva, Ellina M Iakupova, Albina A Fakhretdinova, Azaliia M Tuliakova, Songhomitra Panda-Jonas, Iuliia A Rusakova, Ildar F Nuriev and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Mukharram M BikbovUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077. Bikbov.m@gmail.com.
Timur R GilmanshinUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Rinat M ZainullinUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Gyulli M KazakbaevaUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Ellina M IakupovaUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Albina A FakhretdinovaUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Azaliia M TuliakovaUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Songhomitra Panda-JonasPrivatpraxis Prof Jonas und Dr Panda-Jonas, Heidelberg, Germany.
Iuliia A RusakovaUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Ildar F NurievUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Artur F ZaynetdinovUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Liana A MiniazevaUfa Eye Research Institute, 90 Pushkin Street, Ufa, Russia, 450077.
Jost B JonasPrivatpraxis Prof Jonas und Dr Panda-Jonas, Heidelberg, Germany. Jost.Jonas@medma.uni-heidelberg.de.
Ufa Eye Research Institute · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the prevalence of dry eye disease (DED) and Meibomian gland dysfunction (MGD) in a population in Russia. The population-based Ural Eye and Medical Study was conducted in an urban and rural region in Bashkortostan/Russia and included 5899 (80.5%) out of 7328 eligible persons, aged 40 + years. DED and MGD were assessed by Schirmer´s test, slit-lamp based examination of the Meibomian glands, and an interview with DED-related questions. The study included 5153 (87.4%) individuals with DED and MGD assessments (mean age: 58.5 ± 10.5 years). The mean Schirmer´s test result was 11.8 ± 6.8 mm and 12.5 ± 7.1 mm for the right/left eye, with a result of ≤ 5 mm measured in 1098 (21.3%; 95% confidence intervals (CI) 20.2, 22.4) of the worse eyes. The mean subjective dry eye symptoms score was 1.37 ± 1.82. MGD grade 1 (telangiectasia at the lid margin), 2, 3, 4 or any grade in the worse eye was diagnosed in 901 (21.1%), 1161 (27.1%), 158 (3.7%), 32 (0.7%), and 2252 (52.6%; 95% CI 51.1, 54.1) eyes respectively. The prevalence of DED diagnosis #1, #2 and #3 (Schirmer´s test ≤ 5 mm, and dry eye score ≥ 1, ≥ 2, and ≥ 3, respectively), #4 (dry eye score ≥ 1, Schirmer test ≤ 5 mm, MGD grade 1 +), and #5 (dry eye score ≥ 1, Schirmer test ≤ 5 mm, MGD grade 2 +) were 598/5142 (11.6%), 426/5153 (8.3%), 273/5142 (5.3%), 335/5142 (6.5%), and 186/5142 (3.6%), respectively. Mean depression score as applied was 5.1 ± 3.8. Higher DED prevalence (definition #4) was associated (multivariable analysis) with female sex (odds ratio (OR) 1.71; 95% CI 1.31, 2.22; P < 0.001), higher depression score (OR 1.04; 95% CI 101, 1.07; P = 0.009), and higher prevalence of thyroid disease history (OR 1.63; 95% CI 1.19, 2.24; P = 0.006). DED and MGD were common in this rural and urban population, and their prevalence was associated with female sex, thyroid disease, and depression.

Indexed as

Dry Eye SyndromesMeibomian Gland DysfunctionAgedFemaleHumansMeibomian GlandsMiddle AgedPrevalenceTears

Identifiers

PMID36344615
PMCPMC9640718
OpenAlexW4308768857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.